ScreenerHero

URT Urteste S.A.

GPW · PL · Healthcare · Biotechnology · urteste.eu
41.80PLN-0.95%Mkt Cap: 16.16M $P/E: —

Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap16.16M USD
Enterprise Value16.16M USD
Revenue (TTM)702.04K USD
Gross Profit-59.26K USD
Net Income (TTM)-1.51M USD
Revenue/Share1.88 PLN
Last Price41.80 PLN
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLURTST00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-29.86
EV/Revenue23.02
P/S23.01
P/B2.86
EPS (TTM)-4.94
EPS (Forward)—
52W Range
24.0037% of range72.20
52W High72.20 PLN
52W Low24.00 PLN
Profitability
Gross Margin-1063.64%
Oper. Margin239.66%
EBITDA Margin-77.09%
Profit Margin-27186.36%
ROE-23.99%
ROA-13.25%
Growth
Revenue Growth55.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.70M USD
CapEx (TTM)3.14M USD
FCF Margin-376.50%
FCF Yield-16.36%
Net Debt-148.92K USD
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity0.12
Current Ratio2.15
Quick Ratio2.15
Book Value/Sh14.62 PLN
Cash/Share0.86 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 PLN
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.53M
Float384.10K
Insiders69.59%
Institutions13.64%
Technical
SMA 5043.47 (-3.8%)
SMA 20046.20 (-9.5%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)894
Avg Vol (10d)884
Technical Indicators
RSI (14)44.0
MACD-0.6637
MACD Signal-0.3988
MACD Hist.-0.2649
BB Upper47.60 PLN
BB Middle43.73 PLN
BB Lower39.86 PLN
BB Width17.70%
ATR (14)2.583 PLN
Vol Ratio (20d)8.05x